NDC Package 0078-0925-25 Maxidex

Dexamethasone Suspension/ Drops Ophthalmic - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0078-0925-25
Package Description:
5 mL in 1 BOTTLE
Product Code:
Proprietary Name:
Maxidex
Non-Proprietary Name:
Dexamethasone
Substance Name:
Dexamethasone
Usage Information:
This medication is used to treat certain eye conditions due to inflammation or injury. Dexamethasone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. This medication may also be used to treat swelling, redness, and itching of the outer ear due to inflammatory conditions.
11-Digit NDC Billing Format:
00078092525
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
5 ML
NDC to RxNorm Crosswalk:
  • RxCUI: 205669 - Maxidex 0.1 % Ophthalmic Suspension
  • RxCUI: 205669 - dexamethasone 1 MG/ML Ophthalmic Suspension [Maxidex]
  • RxCUI: 205669 - Maxidex 1 MG/ML Ophthalmic Suspension
  • RxCUI: 309692 - dexAMETHasone 0.1 % Ophthalmic Suspension
  • RxCUI: 309692 - dexamethasone 1 MG/ML Ophthalmic Suspension
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Novartis Pharmaceuticals Corporation
    Dosage Form:
    Suspension/ Drops - A suspension which is usually administered in a dropwise fashion.
    Administration Route(s):
  • Ophthalmic - Administration to the external eye.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA013422
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    05-15-1966
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0078-0925-25?

    The NDC Packaged Code 0078-0925-25 is assigned to a package of 5 ml in 1 bottle of Maxidex, a human prescription drug labeled by Novartis Pharmaceuticals Corporation. The product's dosage form is suspension/ drops and is administered via ophthalmic form.

    Is NDC 0078-0925 included in the NDC Directory?

    Yes, Maxidex with product code 0078-0925 is active and included in the NDC Directory. The product was first marketed by Novartis Pharmaceuticals Corporation on May 15, 1966 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0078-0925-25?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume. The calculated billable units for this package is 5.

    What is the 11-digit format for NDC 0078-0925-25?

    The 11-digit format is 00078092525. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20078-0925-255-4-200078-0925-25